Ver mas grande
CASP9 antibody
FT-FNab01297
Producto nuevo
100 µg
Comprando este producto generará 2 Biopuntos. Su cesta contiene un total 2 Biopuntos puede ser convertido en un Biobonos Descuento 8.00EUR.
Hoja técnica
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC, IP, IF |
| Target | CASP9 |
| Research Area | Metabolism |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | monoclonal |
| Immunogen | caspase 9, apoptosis-related cysteine peptidase |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | Caspase-9 (CASP-9)|Apoptotic protease Mch-6|Apoptotic protease-activating factor 3 (APAF-3)|ICE-like apoptotic protease 6 (ICE-LAP6)|Caspase-9 subunit p35|Caspase-9 subunit p10|CASP9|MCH6 |
| Host | Mouse |
| UniProt ID | P55211 |
| Gene ID | 842 |
| Purification | Protein A+G purification |
| Clone Number | 1F9 |
| Iso type | IgG1 |
| Reactivity | Human, Mouse, Rat |
| Observed MW | 46 kDa, 36 kDa |
| Background | Caspase 9, apoptosis-related cysteine protease(CASP9, synonyms: MCH6, APAF3, APAF-3, ICE-LAP6, CASPASE-9c)is a member of the cysteine-aspartic acid protease(caspase) family. Sequential activation of caspases plays a central role in the execution-phase of |
Más información
Caspase 9 antibody